Folic Acid Reduced Triglycerides Deposition in ... - ACS Publications

Nov 28, 2018 - 100 U/mL penicillin, and 100 mg/mL streptomycin (Gibco) at 37 °C .... Otherwise, a nonparametric test (Mann−Whitney U test) is used for...
0 downloads 0 Views 1MB Size
Subscriber access provided by University of Rhode Island | University Libraries

Bioactive Constituents, Metabolites, and Functions

Folic Acid Reduced Triglycerides Deposition in Primary Chicken Hepatocytes Yanli Liu, Jing Shen, Xin Yang, Qingzhu Sun, and Xiaojun Yang J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.8b05193 • Publication Date (Web): 28 Nov 2018 Downloaded from http://pubs.acs.org on December 4, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 41

Journal of Agricultural and Food Chemistry

1

Folic Acid Reduced Triglycerides Deposition in Primary Chicken Hepatocytes

2

Yanli Liu, Jing Shen, Xin Yang, Qingzhu Sun, Xiaojun Yang*

3 4

College of Animal Science and Technology, Northwest A&F University, Yangling, China

5 6

*Corresponding Author:

7

Xiaojun Yang: College of Animal Science and Technology, Northwest A&F University,

8

No.22 Xinong Road, Yangling, Shaanxi, China; Postal code:712100.

9

Tel: 86 029 87092102;

10

Fax: 86 029 87092341;

11

E-mail: [email protected] (Xiaojun Yang);

12 13 14

1 ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

15

ABSTRACT

16

Abdominal fat or fatty liver cause huge economic loss in poultry industry and nonalcoholic

17

fatty liver disease (NAFLD) is also a global health issue in human. More than 90% of de novo

18

lipogenesis in human and chickens is undertaken by the liver which is proved to be full of lipid

19

in new-born chickens. Folic acid was thought to have correlation with lipid metabolism.

20

Primary hepatocytes from new-born chickens were employed as a natural model of early stage

21

fatty liver in vitro and further to explore whether folic acid could prevent fatty liver in the

22

current study. We found that folic acid addition reduced triglyceride deposition by suppressing

23

de novo fatty acid synthesis and coordinately promoting triglyceride hydrolysis and exportation

24

in primary chicken hepatocytes from new-born chickens. In addition, lipogenesis suppression

25

was through PI3K/AKT/SREBP pathway mediated by weakening insulin/IGF signal. Our data

26

suggested that folic acid may be considered as a precautionary strategy for abdominal fat

27

deposition in broilers or fatty liver in laying hens and humans. In addition, mechanism

28

regulation also implied that IGF2 inhibitor and PI3K inhibitor may be used for the NAFLD

29

precautionary measure to reduce TG deposition.

30

KEYWORDS: folic acid; hepatocytes; lipid metabolism; insulin-like growth factor 2

31

2 ACS Paragon Plus Environment

Page 2 of 41

Page 3 of 41

32

Journal of Agricultural and Food Chemistry

INTRODUCTION

33

Nowadays, commercial genetic breeding selection of meat-type chickens significantly

34

increased body weight and breast meat yield while higher abdominal fat was also accompanied

35

because there were positive inheritance and genetic relationships between body weight and

36

abdominal fat 1. The fatness negatively affected ketone body production, meat quality and feed

37

utilization efficiency 2. In addition, fatty liver is a metabolic disease and widespread in laying

38

hens, but it is often ignored because its symptoms are not obvious as infectious diseases 3.

39

Nevertheless, fatty liver can decrease egg production, fertilization rate and hatching rate,

40

ultimately causing huge economic losses in poultry industry 4. Unlike rodents and rabbits whose

41

adipose tissues and livers contributed equally to de novo lipogenesis 5, more than 90% of de

42

novo lipogenesis in human and chickens is undertaken by the liver 6. Therefore, chickens have

43

been widely accepted and used as an animal model for human disease research about lipid

44

metabolism 7, 8. Adult laying hens have been used to identify biomarkers as potential diagnostic

45

indicators for human nonalcoholic fatty liver disease (NAFLD) 9, which is a global health issue

46

with an estimated prevalence between 20%-68% in different countries 10. Hence, it is necessary

47

to find ways to avoid fatty liver for human health and reducing poultry industry loss.

48

Hepatic triglyceride accumulation results from the imbalance among de novo lipogenesis,

49

free fatty acid uptake, fatty acid oxidation, triglyceride (TG) hydrolysis and export 11, and it is

50

a complex disorder involving in genetic predisposition and environmental factors such as diets.

51

It was reported that methyl donor deficient diets might contribute to hepatic lipid accumulation

52

by suppression of very low-density lipoprotein (VLDL) assembly machinery

53

methyl-donors could increase fatty acid utilization and prevent hepatic lipid accumulation in 3 ACS Paragon Plus Environment

12.

Dietary

Journal of Agricultural and Food Chemistry

54

NAFLD by activating AMPK 13. Paternal dietary B vitamins difference could cause the variance

55

in hepatic total cholesterol, triglycerides and lipid metabolism genes expression of female

56

offspring 14. Folic acid, as a water soluble B vitamin, is involved in one-carbon metabolism and

57

has been also reviewed to have many potential mechanisms linking its deficiency to fatty liver

58

disease15. Yu et al found that folic acid addition could reduce FAS and C/EBPα expression by

59

changing methylation level of gene promoter 16. Low serum folic acid levels were identified as

60

an independent risk factor for NAFLD in the Chinese population 17. Hence, folic acid may be

61

likely to alleviate fatty liver to some extent, but the mechanism is less known.

62

It was reported that 80% lipid content of the yolk was absorbed into the embryonic liver

63

during last seven days of chicken embryo development and hepatic lipid contents reached the

64

higher level in new-born chickens 18. Hematoxylin-eosin (HE) and oil red O staining we did for

65

the liver of new-born chicken also showed that it is full of lipid (as shown in Figure 1A and

66

1C). In addition, hepatocytes from newborn chicken were proved to be abundant in lipid

67

droplets by Oil Red O staining (Figure 1E) and electron microscopy observation (Figure 1F).

68

Therefore, primary chicken hepatocytes from new-born chicken could be a better model for the

69

fatty liver of early stage in vitro to some extent. Thus, primary hepatocytes from new-born

70

chickens were isolated in the current study and employed to ascertain the regulation mechanism

71

of folic acid on fatty liver in vitro, aiming to provide theoretical basis for improving the current

72

situation of abdominal fat deposition in broilers or NAFLD in poultry and in human.

73

MATERIALS AND METHODS

74

Lipid analysis for the liver and hepatocytes from new-born chicken

75

Liver samples were fixed for 24 h with 4% formaldehyde at room temperature. Fixed liver 4 ACS Paragon Plus Environment

Page 4 of 41

Page 5 of 41

Journal of Agricultural and Food Chemistry

76

samples were processed for sectioning and then stained with HE or oil red O by Wuhan goodbio

77

technology Co., Ltd. (Wuhan, China). In addition, Hepatocytes from newborn chicken was

78

collected for electron microscopy analysis by Wuhan goodbio technology Co., Ltd. (Wuhan,

79

China). The animal protocol was performed in sterile conditions and approved by the Animal

80

Care and Use Committee of the College of Animal Science and Technology of the Northwest

81

A&F University (Shaanxi, China).

82

Isolation and culture of primary chicken hepatocytes

83

Hepatocytes were isolated from male new-hatched chickens by collagenase digestion and

84

filtration according to previous description 19-23 with some modifications, and specific isolation

85

process were described in the previous report 24. After 12 h attachment incubation in culture

86

medium containing 10% FBS (Biowest, Nuaile, France), 10 μg/mL human transferrin (Sigma),

87

5 μg/mL bovine insulin (Sigma), 10-6 mol/L dexamethasone (Sigma), 100 U/mL penicillin, 100

88

mg/mL streptomycin (Gibco) at 37 oC in a humidified atmosphere with 5% CO2, hepatocytes

89

were washed with PBS and replaced with fresh culture medium. When reaching about 80%

90

confluence, cells were washed and changed with treatment culture mediums for another12 h.

91

RPMI 1640 Medium (Cat No. 11875) used in the current study was purchased from Gibco Co.

92

Ltd which contained 1 mg/L folic acid.

93

For treatments with folic acid, there was two groups, one for the control and another one

94

for folic acid addition group with 15 mg/L folic acid in the culture medium. This dosage was

95

based on the study from Yu et al 25 and our preliminary experiment 26, and data were not shown

96

here. The folic acid from Sigma (St. Louis, MO) was dissolved with the aid of a minimal volume

97

of 10% ammonium hydroxide and adjusted to 500 mg/L in deionized water, then filtered using 5 ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

Page 6 of 41

98

0.22-μm filters 25. The stock solution was diluted further in RPMI 1640 medium to reach the

99

final 15 mg/L concentration.

100

For treatments with IGF2 and IGF2 inhibitor, there are three groups: one for the control,

101

one for IGF2 (recombinat human IGF2 protein, R&D Systems) with 20 ng/mL in the medium

102

and one for chromeceptin (Sigma-Aldrich) with 5μg/mL in the medium. The dosage of IGF2

103

and chromeceptin used in the study was referred the previous study

104

LY294002 (50 μM) was used as a pharmacological inhibitor of the PI3K/AKT pathway, and

105

cells were pretreated with the compound 2 h prior to stimulation with 20 ng/mL IGF2. Optimal

106

inhibition was obtained with this concentration as previous study 30.

107

Metabolomic analysis

108

Metabolites extraction, derivatization and GC-MS analysis

109

cells were washed with PBS twice, and 300 μL ice-cold methanol were added to collect cells

110

into tubes using wipers, then same volume ice water were mixed with methanol. Preliminary

111

treatment about metabolites extraction and derivatization for samples was performed according

112

to the previous method 24. Metabolomics instrumental analysis was performed on an Agilent

113

7890A gas chromatography system coupled to an Agilent 5975C inert MSD system (Agilent

114

Technologies Inc., CA, USA). A HP-5ms fused-silica capillary column (30 m × 0.25 mm ×

115

0.25μm; Agilent J&W Scientific, Folsom, CA) was utilized to separate the derivatives. Detailed

116

separation conditions and data collection were based on the previous report 24.

117

Identification of differential metabolites

118

further processing of raw GC-MS data were referred to the previous published protocols

119

Multivariate statistical analysis was performed using SIMCA (version 13.0, Umetrics AB,

27-29.

PI3K inhibitor

After appropriate treatments,

The peak picking, alignment, deconvolution, and

6 ACS Paragon Plus Environment

31.

Page 7 of 41

Journal of Agricultural and Food Chemistry

120

Umeå, Sweden) after normalizing against total peak abundance. The quality of the models is

121

described by the R2X or R2Y and Q2 values. The differential metabolites were determined by

122

the combination of the variable importance in the projection (VIP) value (>1) of orthogonal

123

partial least squares discriminant analysis (OPLS-DA) model and the p values (